Study Stopped
PI left Stanford
Cognitive Enhancement Program in Improving Cognitive Function in Breast Cancer Survivors
3 other identifiers
interventional
N/A
1 country
1
Brief Summary
This randomized clinical trial studies cognitive enhancement program in improving cognitive function in breast cancer survivors. A cognitive enhancement program may help improve cognitive function in breast cancer survivors and may help doctors plan better treatment for cognitive decline.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2013
CompletedStudy Start
First participant enrolled
January 1, 2014
CompletedFirst Posted
Study publicly available on registry
June 18, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2016
CompletedNovember 24, 2014
November 1, 2014
2 years
December 16, 2013
November 21, 2014
Conditions
Outcome Measures
Primary Outcomes (1)
Standardized Executive Function Test Composite Score
Baseline to 3 months
Study Arms (3)
Arm IA (Lumosity, relaxation, compensatory strategies)
EXPERIMENTALParticipants complete Lumosity cognitive exercises. Lumosity cognitive exercises are online video game-based activities that are designed to practice various cognitive skills including processing speed, attention, memory and executive function. Participants complete cognitive exercises at least 20 minutes a day, 5 days a week for 6 weeks. Participants also complete relaxation exercises (guided imagery, progressive muscle relaxation, and/or autogenics) at least 10 minutes a day for 6 weeks and compensatory strategies (the use of external devices such as a notebook, day planner, or smartphone for cuing, reminding, and organizing; the use of memory strategies such as repetition, paraphrasing, and active listening; and the use of executive strategies such as self-talk for planning and attention orientation) as much as possible.
Arm IB (Active Journaling, relaxation, compensatory strategy)
EXPERIMENTALParticipants complete Active Journal cognitive exercises. Active Journaling requires participants to keep a written diary or journal where she discusses what her thoughts and feelings about various events with a focus on describing the meaning of the activities and experiences, particularly new things that were learned. Active Journaling is a method of practicing various cognitive skills including communication, organization, memory and executive function. Participants complete cognitive exercises at least 20 minutes a day, 5 days a week for 6 weeks. Participants also complete relaxation exercises and compensatory strategies as in Arm IA.
Arm II (Lumosity only)
EXPERIMENTALParticipants complete Lumosity exercises as in Arm IA.
Interventions
Complete Lumosity cognitive exercises
Complete Active Journaling cognitive exercises
Complete relaxation exercises
Complete compensatory strategies
Ancillary studies
Eligibility Criteria
You may qualify if:
- Previous diagnosis of breast cancer
- Received chemotherapy treatment for breast cancer diagnosis
- Chemotherapy-free for at least one year
You may not qualify if:
- History of learning disability, head trauma, neurologic disorder or significant psychiatric condition
- Significant medical condition (e.g. diabetes) unrelated to cancer diagnosis
- Magnetic resonance imaging (MRI) contraindications (e.g. metallic biomedical implants)
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Stanford Universitylead
- National Cancer Institute (NCI)collaborator
Study Sites (1)
Stanford University Hospitals and Clinics
Stanford, California, 94305, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Shelli Kesler
Stanford University Hospitals and Clinics
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 16, 2013
First Posted
June 18, 2014
Study Start
January 1, 2014
Primary Completion
January 1, 2016
Last Updated
November 24, 2014
Record last verified: 2014-11